Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Rupert McShane has just published results from a study he led looking at the use of ketamine intravenous infusions in people with treatment-resistant depression The study, published in the Journal of Psychopharmacology, confirmed that ketamine has a rapid antidepressant effect in some patients with severe depression who have not responded to other treatments.

First uk study of ketamine for people with severe depression

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk